Cdk5-Dependent Activation of Neuronal Inflammasomes in Parkinson's Disease-Reference-Cited by-同舟云学术

Cdk5-Dependent Activation of Neuronal Inflammasomes in Parkinson's Disease

Published:2016-02-08 Issue:3 Volume:31 Page:366-376
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Zhang Pei¹²³,Shao Xiao-Yun¹²³,Qi Guang-Jian¹²³,Chen Qiang¹²³,Bu Lu-Lu¹²³,Chen Li-Jun¹²³,Shi Jing¹²³,Ming Jie⁴,Tian Bo¹²³

Affiliation:

1. Department of Neurobiology; Tongji Medical School, Huazhong University of Science and Technology; Wuhan Hubei Province P. R. China

2. Key Laboratory of Neurological Diseases, Ministry of Education; Wuhan Hubei Province P. R. China

3. Institute for Brain Research, Huazhong University of Science and Technology; Wuhan Hubei Province P. R. China

4. Union Hospital, Huazhong University of Science and Technology; Wuhan Hubei Province P. R. China

Funder

National Natural Science Foundation of China

New Century Excellent Talents in University

China Postdoctoral Science Foundation

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Reference46 articles.

1. Parkinson's disease: genetics and pathogenesis;Shulman;Annu Rev Pathol,2011

2. [Roles of metabolic compartmentalization by astrocytes and neurons in the pathophysiology and treatment of Parkinson's disease];Takahashi;Brain Nerve,2013

3. The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease;Zuo;Gene,2013

4. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases;Lin;Nature,2006

5. Somatic mitochondrial DNA mutations in cortex and substantia nigra in aging and Parkinson's disease;Simon;Neurobiol Sging,2004

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting NLRP3 Inflammasomes: A Trojan Horse Strategy for Intervention in Neurological Disorders;Molecular Neurobiology;2024-07-23

2. Ketone body metabolism and the NLRP3 inflammasome in Alzheimer's disease;Immunological Reviews;2024-07-11

3. Pyroptosis-mediator GSDMD promotes Parkinson’s disease pathology via microglial activation and dopaminergic neuronal death;Brain, Behavior, and Immunity;2024-07

4. Inflammation, Autoimmunity and Neurodegenerative Diseases, Therapeutics and Beyond;Current Neuropharmacology;2024-05

5. Role of NLRP3 Inflammasomes in Neurodegenerative Diseases;The Eurasian Journal of Medicine;2024-02-28